Cargando…
IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype
Hepatocellular carcinoma (HCC) represents the third leading cause of cancer-related deaths and commonly develops in inflammatory environments. The IGF2 mRNA-binding protein IMP2-2/IGF2BP2-2/p62 was originally identified as an autoantigen in HCC. Aim of this study was to investigate a potential patho...
Autores principales: | Kessler, S M, Laggai, S, Barghash, A, Schultheiss, C S, Lederer, E, Artl, M, Helms, V, Haybaeck, J, Kiemer, A K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632283/ https://www.ncbi.nlm.nih.gov/pubmed/26426686 http://dx.doi.org/10.1038/cddis.2015.241 |
Ejemplares similares
-
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer
por: Kessler, Sonja M., et al.
Publicado: (2017) -
The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma
por: Kröhler, Tarek, et al.
Publicado: (2019) -
Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma
por: Barghash, Ahmad, et al.
Publicado: (2016) -
The long non-coding RNA H19 suppresses carcinogenesis and chemoresistance in hepatocellular carcinoma
por: Schultheiss, Christina S., et al.
Publicado: (2017) -
The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer
por: Dahlem, Charlotte, et al.
Publicado: (2019)